Related Experiment Videos
[Bowenoid papulosis: myth or reality?].
1Università degli Studi, Clinica Dermatosifilopatica, Viale del Policlinico, 155, 00100 Roma.
Minerva Ginecologica
|August 31, 2001
Summary
Bowenoid Papulosis (P.B.) review questions the Human Papillomavirus (HPV) role in its development despite its clear involvement. Research explores alternative etiopathogenesis and conservative "wait and see" therapeutic approaches due to treatment side effects.
Area of Science:
- Dermatology
- Oncology
- Virology
Context:
- Bowenoid Papulosis (P.B.) is a condition with debated etiopathogenesis.
- Recent clinical observations prompt a review of existing theories.
- The role of Human Papillomavirus (HPV) in P.B. requires further clarification.
Purpose:
- To review current theories on the clinical entity of Bowenoid Papulosis.
- To consider histological and etiopathogenesis aspects of P.B.
- To evaluate the role of HPV and patient immunology in P.B. development.
Summary:
- While HPV is implicated in P.B. initiation and growth, its direct etiopathogenic role is questioned due to its absence in some examined cases.
- Patient immunology is considered as a factor in the frequent spread of P.B., despite no significant deficits found in previous cases.
- Therapeutic strategies for P.B. are debated, with a "wait and see" approach considered due to potential harm from treatments like local therapies and podophyllotoxins.
Impact:
- This review highlights the need for further research into the precise causes of Bowenoid Papulosis.
- It suggests a re-evaluation of treatment protocols, potentially favoring less invasive methods.
- Understanding the immunological factors could lead to more targeted P.B. management strategies.